For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

Down syndrome is caused by an extra copy of chromosome 21. Because of genes present on this chromosome that are known to ...

New research published in the journal eNeuro examined whether eliminating a protein that is elevated in the brains of those ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

New findings show that removing Centaurin-α1, a protein elevated in Alzheimer’s disease, significantly reduces inflammation, plaque buildup, and cognitive deficits in a well-established mouse model.

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

Semaglutide lowered inflammation, but not cognitive decline ...